BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

IHH Healthcare Launches Global Incubator Programme to Empower Early-Stage Startups

By enabling early-stage start-ups to bring breakthrough ideas to life, IHH is catalysing next-level care and driving lasting impact across the healthc...

October 13, 2025 | News

Eppendorf Launches Deepwell Plates BioBased to Advance Sustainable Laboratory Practices

Eppendorf is proud to announce the launch of its Deepwell Plates BioBased, made from min. 95 % second-generation feedstock (according to mass-balan...

October 10, 2025 | News

Samsung Biologics Launches ExellenS™ Framework to Standardise and Accelerate Global Biomanufacturing

ExellenS TM applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed ExellenS TM&nbs...

October 10, 2025 | News

Thermo Fisher Introduces Gene Expression Profiling Test to Improve Precision in Lung Transplant Rejection Assessment

New gene expression profiling test enhances precision in assessing lung transplant rejection and injury Thermo Fisher Scientific, the world leader in serv...

October 09, 2025 | News

RoosterBio and Secretome Therapeutics Achieve Commercial-Scale Production Milestone for Lead Cell Therapy STM-01

RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and...

October 07, 2025 | News

AbbVie’s BOTOX® Achieves Primary and Secondary Endpoints in Phase 2 ELATE Trial for Essential Tremor

OnabotulinumtoxinA (BOTOX®) met the primary endpoint in the Phase 2 trial, demonstrating a statistically significant improvement ...

October 07, 2025 | News

Lonza Expands GMP Portfolio with TheraPEAK® AmpliCell® Cytokines and 293-GT® Medium for Enhanced Cell and Gene Therapy Manufacturing

AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK&r...

October 07, 2025 | News

Turning Signals into Cures: The Big Data Blueprint for Cell Therapy Factories

Cell therapy manufacturing is entering a data-driven era, as the industry grapples with complex production processes, high costs, and the need for personal...

October 07, 2025 | Analysis

Japan’s Daiichi Sankyo Expands Global R&D Footprint with New Research Institute in San Diego

Daiichi Sankyo (TSE: 4568) has established Daiichi Sankyo Research Institute in San Diego, representing the third research institute established outside of...

October 06, 2025 | News

CTMC Partners with Einstein Hospital Israelita to Accelerate Cell Therapy Adoption in Brazil and Latin America

CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has entered into a collaborative partnership with Einstein Hospital Israelita&...

October 03, 2025 | News

Thermo Fisher’s PPD™ Clinical Research Joins AstraZeneca BioVentureHub for R&D Partnership in Sweden

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development ...

October 02, 2025 | News

Made Scientific and Syenex Forge Partnership to Transform T Cell Therapy Manufacturing

Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in ...

October 01, 2025 | News

Lumonus Partners With Smarter Radiation Oncology® to Expand AI-Driven, Standardised Cancer Care Worldwide

Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, announced a multi-year agreement with Smarter Radiation Onc...

September 30, 2025 | News

Polpharma Biologics Restructures into Two Companies: Biosimilars and Rezon Bio CDMO

Polpharma Biologics announced a strategic corporate transformation, demerging into two independent companies to strengthen focus and accelerate growth acro...

September 30, 2025 | News

Stay Connected